The page is the record's research on the issuer — no analyst, no rating, no view. # Prelude Therapeutics Inc (NASDAQ: PRLD) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing Prelude Therapeutics Inc is listed on NASDAQ under the ticker PRLD. Its ISIN is US74065P1012. Its LEI is not on the record, as no GLEIF record with the exact legal name in jurisdiction US-DE was found. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. Its status is listed, not halted. ## The disclosure read The record holds 48 filings in the twelve months to 2026-11-08, across 24 filing days. The median gap between filing days is 7 days. The latest filing is dated 2026-09-10 and is of type corporate_news, which is 59 days before the record date. The NASDAQ median gap is 6.0 days across 4359 issuers, and the NASDAQ median latency is 5.0 days. The 2834 Pharmaceutical Preparations sector median gap is 6.0 days across 526 issuers, and its median latency is 4.0 days. The window holds 18 directors_dealings, 9 regulatory_filing, 8 results, 6 corporate_news, 3 agm_egm, 3 prospectus and 1 director_change filing. ## Auditor The auditor of record is Ernst & Young LLP, located in Philadelphia, Pennsylvania. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting, name change or segment move lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The issuer is listed and not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer is held in sealed years 2021, 2022, 2023, 2024, 2025 and 2026. The earliest sealed date of the US market is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001678660.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/PRLD (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1678660/000119312526099428/prld-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/PRLD (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/PRLD · public-record only · the same page signed and receipted: get_research at https://mcp.getissuer.ai/mcp